Aescin: pharmacology, pharmacokinetics and therapeutic profile

This publication has 14 references indexed in Scilit:

• Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice
  Life Sciences, 2000
• Three Treatments for Chronic Venous Insufficiency: Escin, Hydroxyethylrutoside, and Daflon
  Angiology, 2000
• Escin in pharmaceutical oral dosage forms: quantitative densitometric HPTLC determination
  Il Farmaco, 1999
• Effect of aescine on hypoxia-induced activation of human endothelial cells
  European Journal of Pharmacology, 1996
• Anti‐Elastase and Anti‐Hyaluronidase Activities of Saponins and Sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: Factors Contributing to their Efficacy in the Treatment of Venous Insufficiency
  Archiv der Pharmazie, 1995
• Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells.
  Journal of Clinical Investigation, 1994
• Vasodilator and vasoconstrictor substances produced by the endothelium
  Published by Springer Nature ,1993
• Calcium-requirement for activation of skinned vascular smooth muscle from spontaneously hypertensive (SHRSP) and normotensive control rats
  Life Sciences, 1986
• Wirkung von Roßkastaniensamenextrakt auf die transkapilläre Filtration bei chronischer venöser Insuffizienz
  Deutsche Medizinische Wochenschrift (1946), 1986
• The mode of action of aescin on isolated veins: Relationship with PGF2α
  Pharmacological Research Communications, 1978